Table 3

Type and schedules of adjuvant chemotherapy prescribed (n = 1095)
Type of chemotherapy N (%)
CMF-like 100 (9.1)
· Anthracyclines alone (without Taxanes) 534 (48.8)
· Anthracyclines plus Taxanes 420 (38.4)
· Taxanes alone (without Anthracyclines) 41 (3.7)
Type of Taxane
· Docetaxel 359 (32.8)
· Paclitaxel 102 (9.3)
Main chemotherapeutic schedules administered
· Oral classical CMF 6 cycles 24 (2.2)
· CMF 6 cycles iv day 1 and 8 q28d 53 (4.8)
· CMF 6 cycles iv day 1 q21d 9 (0.8)
· CMF 3–4 cycles iv day 1 and 8 q28d 11 (1.0)
· AC 4 cycles 89 (8.1)
· AC 6 cycles 27 (2.5)
· E90C 4 cycles 56 (5.1)
· E75C 4 cycles 9 (0.8)
· FE75C 6 cycles 131 (12.0)
· FE90C 6 cycles 95 (8.7)
· FE100C 6 cycles 29 (2.6)
· FAC 6 cycles 8 (0.7)
· Canadian CEF 6 cycles 16 (1.5)
· Epidoxorubicin 4 cycles – CMF 4 cycles 5 (0.5)
· AC 4 cycles – CMF 3 cycles 15 (1.4)
· FEC 3 cycles - Docetaxel 3 cycles 118 (10.8)
· AC/EC 4 cycles - Docetaxel 4 cycles 127 (11.6)
· TAC 6 cycles + G-CSF 29 (2.7)
· AC/EC 4 cycles - Paclitaxel q3wks 4 cycles 39 (3.6)
· FEC/EC 4 cycles - weekly Paclitaxel x 12 43 (3.9)
· A/EP 4 cycles – CMF 4 cycles 7 (0.6)
· ET 6 cycles 12 (1.1)
· TC 4 cycles 19 (1.7)
· TC 6 cycles 8 (0.7)
· Others 116 (10.6)

C = Cyclophosphamide; M = Methotrexate; F = Fluorouracil; A = Doxorubicin; E = Epirubicin; P = Paclitaxel; T = Docetaxel.

Clavarezza et al.

Clavarezza et al. BMC Cancer 2012 12:216   doi:10.1186/1471-2407-12-216

Open Data